Patients' response status before and after VTD and TD consolidation therapy
| Response status before starting consolidation with VTD . | Response status after consolidation with VTD, N . | Total . | |||||
|---|---|---|---|---|---|---|---|
| CR . | nCR . | VGPR . | PR . | MR/NR/SD . | PD . | ||
| CR | 72 | 2 | 1 | 0 | 0 | 3 | 78 |
| nCR | 11 | 10 | 2 | 0 | 0 | 0 | 23 |
| VGPR | 13 | 5 | 17 | 2 | 0 | 0 | 37 |
| PR | 1 | 3 | 10 | 5 | 0 | 0 | 19 |
| MR or NR or SD | 0 | 0 | 0 | 2 | 1 | 0 | 3 |
| Total | 97 | 20 | 30 | 9 | 1 | 3 | 160 |
| Response status before starting consolidation with VTD . | Response status after consolidation with VTD, N . | Total . | |||||
|---|---|---|---|---|---|---|---|
| CR . | nCR . | VGPR . | PR . | MR/NR/SD . | PD . | ||
| CR | 72 | 2 | 1 | 0 | 0 | 3 | 78 |
| nCR | 11 | 10 | 2 | 0 | 0 | 0 | 23 |
| VGPR | 13 | 5 | 17 | 2 | 0 | 0 | 37 |
| PR | 1 | 3 | 10 | 5 | 0 | 0 | 19 |
| MR or NR or SD | 0 | 0 | 0 | 2 | 1 | 0 | 3 |
| Total | 97 | 20 | 30 | 9 | 1 | 3 | 160 |
| Response status before starting consolidation with TD . | Response status after consolidation with TD, N . | Total . | |||||
|---|---|---|---|---|---|---|---|
| CR . | nCR . | VGPR . | PR . | MR/NR/SD . | PD . | ||
| CR | 59 | 1 | 4 | 1 | 0 | 0 | 65 |
| nCR | 6 | 11 | 4 | 2 | 0 | 0 | 23 |
| VGPR | 7 | 9 | 27 | 0 | 0 | 0 | 43 |
| PR | 2 | 2 | 9 | 13 | 0 | 0 | 26 |
| MR or NR or SD | 1 | 0 | 0 | 2 | 1 | 0 | 4 |
| Total | 75 | 23 | 44 | 18 | 1 | 0 | 161 |
| Response status before starting consolidation with TD . | Response status after consolidation with TD, N . | Total . | |||||
|---|---|---|---|---|---|---|---|
| CR . | nCR . | VGPR . | PR . | MR/NR/SD . | PD . | ||
| CR | 59 | 1 | 4 | 1 | 0 | 0 | 65 |
| nCR | 6 | 11 | 4 | 2 | 0 | 0 | 23 |
| VGPR | 7 | 9 | 27 | 0 | 0 | 0 | 43 |
| PR | 2 | 2 | 9 | 13 | 0 | 0 | 26 |
| MR or NR or SD | 1 | 0 | 0 | 2 | 1 | 0 | 4 |
| Total | 75 | 23 | 44 | 18 | 1 | 0 | 161 |
N indicates number of patients; VTD, bortezomib with thalidomide plus dexamethasone; CR, complete response; nCR, near-CR; VGPR, very good partial response; PR, partial response; MR, minimal response; NR, no response; SD, stable disease; and TD, thalidomide plus dexamethasone.